NASDAQ:BMRN
$97.24
(
2.05%
)
Friday, 31st Mar 2023
BioMarin Pharmaceutical Inc. Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $87.34 | $102.79 | Friday, 31st Mar 2023 BMRN stock ended at $97.24. This is 2.05% more than the trading day before Thursday, 30th Mar 2023. During the day the stock fluctuated 2.23% from a day low at $95.56 to a day high of $97.70. |
| 90 days | $87.34 | $117.77 | |
| 52 weeks | $70.73 | $117.77 |
Historical BioMarin Pharmaceutical Inc. prices
| Date | Open | High | Low | Close | Volume |
| 2022-11-04 | $84.79 | $84.88 | $81.54 | $82.49 | 1 611 317 |
| 2022-11-03 | $84.59 | $85.60 | $83.75 | $84.88 | 1 082 371 |
| 2022-11-02 | $86.12 | $86.22 | $84.07 | $84.17 | 1 917 509 |
| 2022-11-01 | $87.24 | $89.06 | $86.13 | $86.60 | 1 611 132 |
| 2022-10-31 | $89.06 | $89.06 | $85.14 | $86.63 | 1 548 034 |
| 2022-10-28 | $85.67 | $86.95 | $84.30 | $86.77 | 2 084 309 |
| 2022-10-27 | $89.63 | $89.63 | $83.10 | $85.73 | 4 289 036 |
| 2022-10-26 | $91.58 | $92.76 | $91.43 | $92.10 | 1 614 514 |
| 2022-10-25 | $89.63 | $91.66 | $89.45 | $91.47 | 1 633 462 |
| 2022-10-24 | $89.99 | $90.80 | $89.45 | $89.87 | 974 438 |
| 2022-10-21 | $89.30 | $90.81 | $88.94 | $90.01 | 1 302 544 |
| 2022-10-20 | $88.04 | $89.70 | $87.95 | $88.70 | 905 628 |
| 2022-10-19 | $88.45 | $89.43 | $87.80 | $88.35 | 1 157 921 |
| 2022-10-18 | $89.84 | $90.54 | $88.56 | $89.49 | 1 487 047 |
| 2022-10-17 | $87.31 | $89.51 | $87.31 | $88.78 | 961 258 |
| 2022-10-14 | $89.89 | $90.31 | $87.13 | $87.25 | 1 177 103 |
| 2022-10-13 | $87.44 | $90.37 | $87.17 | $89.40 | 1 989 866 |
| 2022-10-12 | $88.67 | $89.69 | $88.02 | $88.95 | 828 669 |
| 2022-10-11 | $87.42 | $89.04 | $87.12 | $88.07 | 1 222 239 |
| 2022-10-10 | $87.84 | $88.81 | $87.39 | $87.45 | 967 949 |
| 2022-10-07 | $91.16 | $91.16 | $87.63 | $88.15 | 1 075 952 |
| 2022-10-06 | $89.25 | $92.06 | $88.75 | $91.48 | 1 539 197 |
| 2022-10-05 | $87.89 | $89.82 | $87.40 | $89.53 | 1 276 492 |
| 2022-10-04 | $87.18 | $88.08 | $85.76 | $87.91 | 1 439 554 |
| 2022-10-03 | $85.64 | $87.43 | $84.57 | $86.70 | 930 643 |
| 2022-09-30 | $84.99 | $86.75 | $84.51 | $84.77 | 1 437 083 |
| 2022-09-29 | $85.65 | $85.79 | $84.27 | $85.06 | 788 016 |
| 2022-09-28 | $84.37 | $86.20 | $83.47 | $85.84 | 1 358 891 |
| 2022-09-27 | $82.87 | $84.43 | $82.54 | $83.44 | 1 265 675 |
| 2022-09-26 | $84.20 | $84.48 | $81.66 | $82.16 | 1 401 663 |
| 2022-09-23 | $84.29 | $84.93 | $83.38 | $84.84 | 1 022 015 |
| 2022-09-22 | $84.45 | $85.24 | $83.71 | $84.92 | 867 938 |
| 2022-09-21 | $86.99 | $87.37 | $85.01 | $85.12 | 459 984 |
| 2022-09-20 | $86.82 | $87.68 | $86.17 | $86.96 | 472 045 |
| 2022-09-19 | $87.92 | $88.02 | $86.83 | $87.70 | 694 566 |
| 2022-09-16 | $87.25 | $88.31 | $86.70 | $88.21 | 1 245 525 |
| 2022-09-15 | $86.63 | $88.21 | $85.73 | $88.09 | 854 973 |
| 2022-09-14 | $86.78 | $87.14 | $85.68 | $86.86 | 963 991 |
| 2022-09-13 | $89.51 | $89.51 | $86.25 | $86.54 | 1 391 425 |
| 2022-09-12 | $90.00 | $90.73 | $88.31 | $90.24 | 1 442 545 |
| 2022-09-09 | $92.29 | $93.23 | $91.82 | $92.93 | 721 877 |
| 2022-09-08 | $91.26 | $93.05 | $90.99 | $93.01 | 964 346 |
| 2022-09-07 | $88.96 | $91.64 | $88.70 | $91.21 | 853 136 |
| 2022-09-06 | $89.64 | $89.92 | $88.29 | $88.85 | 834 270 |
| 2022-09-02 | $91.16 | $91.40 | $89.21 | $89.64 | 644 572 |
| 2022-09-01 | $89.17 | $90.90 | $88.78 | $90.87 | 1 106 532 |
| 2022-08-31 | $90.46 | $91.14 | $89.05 | $89.20 | 1 452 744 |
| 2022-08-30 | $90.30 | $90.92 | $89.28 | $90.19 | 912 450 |
| 2022-08-29 | $89.85 | $91.41 | $89.21 | $90.33 | 748 034 |
| 2022-08-26 | $93.21 | $93.58 | $90.93 | $91.01 | 625 195 |
About BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
